(Q80470323)
Statements
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation (English)
Philip G Thomas
Jacqueline A Lappin
Smita Vaidya
Srinivasan Rajaraman
Kristene K Gugliuzza